Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 5756102, 9 pages
https://doi.org/10.1155/2017/5756102
Research Article

Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases

1Institute of Occupational Diseases, Zhejiang Academy of Medical Sciences, Hangzhou 310013, China
2Department of Pathology, Zhejiang Provincial People’s Hospital, Hangzhou, Zhejiang 310014, China
3Jiading District Center for Disease Control and Prevention, Shanghai 201800, China

Correspondence should be addressed to Jianlin Lou; moc.361@uolnilnaij

Received 3 November 2016; Revised 11 January 2017; Accepted 19 January 2017; Published 1 March 2017

Academic Editor: Vincent Sapin

Copyright © 2017 Shibo Ying et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Figure S1: MMP2 levels in serum from individuals with pleural plaques (PP), asbestosis, MPM, exposed to asbestos, and healthy controls. Figure S2: MMP9 levels in serum from individuals with pleural plaques (PP), asbestosis, MPM, exposed to asbestos, and healthy controls.

  1. Supplementary Material